Agilent Closes $250 Million Acquisition of ACEA a USChina Lab Tools Maker

Agilent Closes $250 Million Acquisition of ACEA, a US-China Lab Tools Maker

Agilent Technologies closed its $250 million acquisition of ACEA Biosciences, a San Diego-Hangzhou company that provides cell analysis tools. ACEA is focused on real-time, live cell analysis of cell function and metabolism.  Founded in 2002, the company has manufacturing and R&D facilities in Hangzhou. In 2015, ACEA raised $30 million from China investors Qiming and Lilly Asia Ventures. Agilent says ACEA's offerings are complementary to its own portfolio of lab tools for life science, diagnostics and applied chemical markets. More details....

Stock Symbol: (NYSE: A)

Share this with colleagues:

More From BioPortfolio on "Agilent Closes $250 Million Acquisition of ACEA, a US-China Lab Tools Maker"